Fernando Lecanda
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 2%
- Bone health and treatments
Papers in
-
- Bone Metabolism and Diseases 9
- Wnt/β-catenin signaling in development and cancer 7
- Connexins and lens biology 7
- RNA Interference and Gene Delivery 5
- RNA Research and Splicing 5
- Oncology 30
- Bone health and treatments 15
- Co-authors
- Roberto Civitelli (13 shared papers)Su‐Li Cheng (8 shared papers)Thomas H. Steinberg (5 shared papers)Louis V. Avioli (4 shared papers)Pamela M. Warlow (5 shared papers)Carolina Zandueta (23 shared papers)Konstantinos Ziambaras (3 shared papers)Silvestre Vicent (13 shared papers)
- Journals
- Journal of Cellular Biochemistry (7 papers)Journal of Bone and Mineral Research (5 papers)Cancer Research (5 papers)Clinical Cancer Research (3 papers)Bone (3 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Fernando Lecanda
76 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 560
- Oncology 895
- Molecular Biology 2.2k
- Immunology and Allergy 137
- Immunology 450
Countries citing papers authored by Fernando Lecanda
This map shows the geographic impact of Fernando Lecanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Lecanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Lecanda more than expected).
Fields of papers citing papers by Fernando Lecanda
This network shows the impact of papers produced by Fernando Lecanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Lecanda. The network helps show where Fernando Lecanda may publish in the future.
Co-authors
The 25 scholars most cited alongside Fernando Lecanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 329 | |
| 2 | 1997 | 235 | |
| 3 | 1998 | 211 | |
| 4 | 2018 | 195 | |
| 5 | 2017 | 192 | |
| 6 | 2014 | 143 | |
| 7 | 1998 | 135 | |
| 8 | 1998 | 125 | |
| 9 | 2012 | 118 | |
| 10 | 2003 | 116 | |
| 11 | 2014 | 111 | |
| 12 | 2015 | 94 | |
| 13 | 2020 | 88 | |
| 14 | 1998 | 86 | |
| 15 | 2008 | 82 | |
| 16 | 2007 | 81 | |
| 17 | 2000 | 79 | |
| 18 | 2018 | 74 | |
| 19 | 2004 | 62 | |
| 20 | 2015 | 57 |
About Fernando Lecanda
Fernando Lecanda is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 76 papers that have together received 3.8k indexed citations. Recurring topics across this work include Bone health and treatments (15 papers), Bone Metabolism and Diseases (9 papers), Wnt/β-catenin signaling in development and cancer (7 papers), Connexins and lens biology (7 papers), Sarcoma Diagnosis and Treatment (6 papers), RNA Interference and Gene Delivery (5 papers), RNA Research and Splicing (5 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Cancer Research (560 citations), Oncology (895 citations), Molecular Biology (2.2k citations), Immunology and Allergy (137 citations) and Immunology (450 citations). Fernando Lecanda has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Roberto Civitelli, Su‐Li Cheng, Thomas H. Steinberg, Louis V. Avioli, Pamela M. Warlow, Carolina Zandueta, Konstantinos Ziambaras, Silvestre Vicent, Sharmin Sheikh and Federico Furlan. Their work appears in journals such as Journal of Cellular Biochemistry, Journal of Bone and Mineral Research, Cancer Research, Clinical Cancer Research and Bone.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.